House Leaders Seek GAO Review Of Possible "Anticipatory Price Gouging" By Drug Firms

Prompted by recent studies indicating drug prices may be rising more quickly than usual, Reps. Waxman and Rangel seek expedited review of pricing trends. Sen. Nelson requests similar review by OIG, pledges Medicare rebate amendment.